The effect of optimised patient information materials on recruitment in a lung cancer screening trial

an embedded randomised recruitment trial

Adwoa Parker (Corresponding Author), Peter Knapp, Shaun Treweek, Vichithranie Madhurasinghe, Roberta Littleford, Stephanie Gallant, Frank Sullivan, Stuart Schembri, Jo Rick, Jonathan Graffy, David J Collier, Sandra Eldridge, Anne Kennedy, Peter Bower (Corresponding Author)

Research output: Contribution to journalArticle

1 Citation (Scopus)
5 Downloads (Pure)

Abstract

Background
Written participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates.

Methods
We conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS.

Results
In total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8%) in the intervention group and 176 of 1126 (15.6%) in the control group (OR = 1.016, 95% CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7%) in the intervention group and 205 of 1126 (18.2%) in the control group (OR = 1.103, 95% CI, 0.778 to 1.565).

Conclusions
Optimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial.
Original languageEnglish
Article number503
JournalTrials
Volume19
DOIs
Publication statusPublished - 18 Sep 2018

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Scotland
Pamphlets
Control Groups
Informed Consent
Incidence

Keywords

  • recruitment
  • patient information
  • research methodology
  • randomised controlled trial
  • Study within a trial (SWAT)

Cite this

The effect of optimised patient information materials on recruitment in a lung cancer screening trial : an embedded randomised recruitment trial. / Parker, Adwoa (Corresponding Author); Knapp, Peter ; Treweek, Shaun; Madhurasinghe, Vichithranie ; Littleford, Roberta; Gallant, Stephanie ; Sullivan, Frank; Schembri, Stuart ; Rick, Jo; Graffy, Jonathan ; Collier, David J; Eldridge, Sandra ; Kennedy, Anne; Bower, Peter (Corresponding Author).

In: Trials, Vol. 19, 503, 18.09.2018.

Research output: Contribution to journalArticle

Parker, A, Knapp, P, Treweek, S, Madhurasinghe, V, Littleford, R, Gallant, S, Sullivan, F, Schembri, S, Rick, J, Graffy, J, Collier, DJ, Eldridge, S, Kennedy, A & Bower, P 2018, 'The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial', Trials, vol. 19, 503. https://doi.org/10.1186/s13063-018-2896-9
Parker, Adwoa ; Knapp, Peter ; Treweek, Shaun ; Madhurasinghe, Vichithranie ; Littleford, Roberta ; Gallant, Stephanie ; Sullivan, Frank ; Schembri, Stuart ; Rick, Jo ; Graffy, Jonathan ; Collier, David J ; Eldridge, Sandra ; Kennedy, Anne ; Bower, Peter. / The effect of optimised patient information materials on recruitment in a lung cancer screening trial : an embedded randomised recruitment trial. In: Trials. 2018 ; Vol. 19.
@article{d3966742267c45fcbf8fabbc7fdd7fd1,
title = "The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial",
abstract = "BackgroundWritten participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates.MethodsWe conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS.ResultsIn total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8{\%}) in the intervention group and 176 of 1126 (15.6{\%}) in the control group (OR = 1.016, 95{\%} CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7{\%}) in the intervention group and 205 of 1126 (18.2{\%}) in the control group (OR = 1.103, 95{\%} CI, 0.778 to 1.565).ConclusionsOptimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial.",
keywords = "recruitment, patient information, research methodology, randomised controlled trial, Study within a trial (SWAT)",
author = "Adwoa Parker and Peter Knapp and Shaun Treweek and Vichithranie Madhurasinghe and Roberta Littleford and Stephanie Gallant and Frank Sullivan and Stuart Schembri and Jo Rick and Jonathan Graffy and Collier, {David J} and Sandra Eldridge and Anne Kennedy and Peter Bower",
note = "The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. The MRC START programme is funded by the MRC Methodology Research Programme (grant reference G1002325). Materials relating to the MRC START programme can be found in the protocol and on the University of Manchester website (http://www.population-health.manchester.ac.uk/mrcstart/). The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates.",
year = "2018",
month = "9",
day = "18",
doi = "10.1186/s13063-018-2896-9",
language = "English",
volume = "19",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The effect of optimised patient information materials on recruitment in a lung cancer screening trial

T2 - an embedded randomised recruitment trial

AU - Parker, Adwoa

AU - Knapp, Peter

AU - Treweek, Shaun

AU - Madhurasinghe, Vichithranie

AU - Littleford, Roberta

AU - Gallant, Stephanie

AU - Sullivan, Frank

AU - Schembri, Stuart

AU - Rick, Jo

AU - Graffy, Jonathan

AU - Collier, David J

AU - Eldridge, Sandra

AU - Kennedy, Anne

AU - Bower, Peter

N1 - The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. The MRC START programme is funded by the MRC Methodology Research Programme (grant reference G1002325). Materials relating to the MRC START programme can be found in the protocol and on the University of Manchester website (http://www.population-health.manchester.ac.uk/mrcstart/). The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates.

PY - 2018/9/18

Y1 - 2018/9/18

N2 - BackgroundWritten participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates.MethodsWe conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS.ResultsIn total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8%) in the intervention group and 176 of 1126 (15.6%) in the control group (OR = 1.016, 95% CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7%) in the intervention group and 205 of 1126 (18.2%) in the control group (OR = 1.103, 95% CI, 0.778 to 1.565).ConclusionsOptimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial.

AB - BackgroundWritten participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates.MethodsWe conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS.ResultsIn total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8%) in the intervention group and 176 of 1126 (15.6%) in the control group (OR = 1.016, 95% CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7%) in the intervention group and 205 of 1126 (18.2%) in the control group (OR = 1.103, 95% CI, 0.778 to 1.565).ConclusionsOptimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial.

KW - recruitment

KW - patient information

KW - research methodology

KW - randomised controlled trial

KW - Study within a trial (SWAT)

U2 - 10.1186/s13063-018-2896-9

DO - 10.1186/s13063-018-2896-9

M3 - Article

VL - 19

JO - Trials

JF - Trials

SN - 1745-6215

M1 - 503

ER -